EuCorVac-19
EuCorVac-19, a recombinant protein vaccine displaying the SARS-CoV-2 receptor-binding domain (RBD) antigen on the immunogenic liposomes

BUFFALO, N.Y., July 14, 2023 (Newswire.com) -  POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical startup, announces top line interim results of a Phase 3 clinical trial of EuCorVac-19, a COVID-19 vaccine candidate being developed by South Korean partner EuBiologics (KOSDAQ: 206650). EuCorVac-19 is a protein-based vaccine consisting of a vaccine antigen displayed on immunogenic nanoparticles, using POP BIO's spontaneous-nanoliposome antigen particle (SNAP) technology.

The phase 3 trial of EuCorVac-19 was conducted in the Philippines in approximately 2,600 adults (NCT05572879). EuCorVac-19 demonstrated superior antibody immunogenicity compared to a World Health Organization Emergency Use Authorized adenoviral vector vaccine, thereby meeting the primary endpoint of the phase 3 trial.

The formation of neutralizing antibodies, which prevent COVID-19 infection, was more than twice as high in EuCorVac-19 compared to the control vaccine. EuCorVac-19 exhibited a high serological response rate with neutralizing antibody titers increasing after vaccination. In particular, the neutralizing antibody titers and serum response rates in subjects aged over 65 exceeded those of the control vaccine. In immunogenicity analysis against the Omicron BA.5 strain, EuCorVac-19 induced more than twice the neutralizing antibody titer compared to the control vaccine.

EuCorVac-19's safety profile was further established in this phase 3 study. EuCorVac-19 showed a slightly lower incidence than the control vaccine of solicited adverse events and there was no difference between EuCorVac-19 and the control vaccine in the incidence of unsolicited adverse events.

These results further validate the strength and synergy of POP BIO's SNAP and EuBiologics' EuIMT platform technologies used in the EuCorVac-19 vaccine. Further development of booster vaccines, new strain vaccines, and combination vaccines for COVID-19 will be significantly more straightforward in the future. 

"Achieving the completion of this Phase III trial is an enormous milestone for our technologies. These results provide validation towards not only solving this unprecedented global crisis but also provides invaluable support towards our platform's development, further enabling the creation of new vaccines with tremendous potential to alleviate suffering worldwide," said POP BIO co-founder Jonathan Smyth.

EuCorVac-19 was already shown to be safe and immunogenic in a Phase I/II clinical trial, the results of which were announced in December 2021. The Philippine Phase 3 trial, conducted since third quarter of 2022, were supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the ministry of Health & Welfare, Republic of Korea.

Based on the results of this clinical study, EuBiologics plans to apply for product approval in the Philippines shortly. Later this year, results will become available from a second independent Phase 3 clinical study being carried out in the Democratic Republic of Congo.

About POP Biotechnologies: POP Biotechnologies, Inc. is a privately held biotechnology company focused on the research and development of novel therapeutics and vaccines employing their proprietary porphyrin-phospholipid (PoP) liposome technologies. The PoP technology, exclusively licensed from the State University of New York Research Foundation (SUNY-RF), was developed by company co-founder Dr. Jonathan Lovell at his academic facilities at The State University of New York at Buffalo (SUNY Buffalo). POP Biotechnologies is currently a resident of the SUNY Buffalo incubator at Baird Research Park.

About POP BIO's SNAP Technology: POP BIO's Spontaneous Nanoliposome Antigen Particleization (SNAP) technology enables the rapid development and manufacturing of highly immunogenic particle-based vaccines and immunotherapies directed against infectious disease and cancer through the use of a cobalt modified variant of the PoP technology (CoPoP). The SNAP technology enables the seamless generation of stable particle-formation and liposome-display of protein and peptide antigens resulting in substantial improvements in immune responses.

About EuBiologics: EuBiologics is a South Korean Biotechnology company that is advancing the EuCorVac-19 COVID-19 vaccine and other vaccine products. EuBiologics has two main animal-based bioreactors (1,000L) to produce recombinant protein antigens at Chuncheon Plant 1(C-Plant) and EcML(Monophosphoryl Lipid A) which is adjuvant at Chuncheon Plant 2(V-Plant). The total capacity of the COVID-19 vaccine is currently in the hundreds of millions of doses per year.

About EuBiologics' EuIMT Technology: EuBioloigcs' Immune Modulation Technology using genetically engineered Monophosphoryl Lipid A (MLA), called EcML that is a unique TLR4 agonist. EuBiologics has IP protection around EcML and various adjuvant systems including EcML. Eubiologics' EcML and POP BIO's SNAP technologies synergize to create ultrapotent next-generation vaccines.

Victoria Headshot
Chief Growth Officer-RCM Solutions of SupportDDS

ARGYLE, Texas, July 14, 2023 (Newswire.com) - SupportDDS is pleased to announce the appointment of Victoria Johnson as the new Chief Growth Officer, RCM Solutions. With over a decade of experience, she has served in progressive leadership roles in dental practices and DSOs specializing in strategy, optimization and implementation of the entire revenue cycle operation. 

Prior to joining SupportDDS, Johnson held various leadership positions at several prominent companies in the industry, including her most recent position as Senior Vice President of Revenue Cycle Management at Select Dental Management. She has a proven track record built on the pillars of creating high-performance cultures, patient satisfaction, operational systems, and practice efficiency.

Johnson is a proud graduate of NC State University. She currently resides in Dallas, Texas, with her husband Jace and two children, Colt and Olivia.

SAN DIEGO, July 14, 2023 (Newswire.com) - Taking care of one's physical well-being is essential on the road to addiction recovery. For the men at Shoreline Recovery Center and Park Mental Health, self-care plays a crucial role. It's through the tailored guidance received from counselors, therapists and support groups that they become self-sustaining individuals.

"We believe that in order to heal and have therapy be the most effective, intentional self-care alongside addiction treatment is essential for recovery," said Mikayla Weathers, Program Director and LMFT at Park Mental Health. "This includes maintaining regular exercise, getting enough sleep, eating a balanced diet and avoiding substances that could trigger a relapse."

When it comes to addiction recovery, men are up against a host of obstacles. Beginning with their emotional well-being, they often face unfair expectations, such as suppressing feelings to remain strong in difficult circumstances.

"Most men have been taught through societal conditioning that having and showing emotions equates to weakness…" Weathers said. "This is why we start by acknowledging how they've been taught to deal with emotions in their childhood and how processing emotions was modeled to them, in order to help them build insight into why they may struggle with this."

Recovery from addiction is often an arduous journey with highs, lows and setbacks, so stress management is a significant aspect of addiction recovery. Regular self-reflection for example, is a tool that can help in understanding triggers, identifying patterns and setting meaningful goals. It's important that time is taken to assess progress, celebrate achievements and adjust things as necessary.

"In early recovery, clients struggle with self-compassion, positive self-talk and self-forgiveness due to the shame and guilt they carry because of their actions during addiction and/or mental health crisis. We normalize each client's emotions and encourage them to shift old patterns of holding onto them to talking about them in peer groups and therapy sessions instead," Weathers said. Often times they haven't been taught how to put their experience into words, which is why psychoeducation is used to teach them about feelings.

Setting realistic short and long-term goals can provide a sense of purpose and direction. Shoreline Recovery Center and Park Mental Health have curriculum groups and therapy sessions to encourage open communication, self-reflection and weekly goal setting.

In addition to self-care and reflection, cultivating healthy relationships and cutting the cord on toxic ones is vital during addiction recovery, which is why staff hold clients accountable to falling back into old patterns and encourage them to make different decisions when it comes to the people they surround themselves with. These men need to have people in their lives who understand and respect their journey.

"Recovery is affected and influenced by every dimension of life, which includes personal and community relationships. Developing healthy relationships, social skills, habits and effective communication skills are an important part of maintaining long-term stability," Weathers said.

NEW YORK, July 14, 2023 (Newswire.com) - Is ketamine a powerful tool for therapeutic purposes? Absolutely. But are there risks associated with its misuse? The answer is a resounding yes. Curated Mental Health, a leading mental health practice in New York City, is dedicated to providing comprehensive and responsible care in the realm of psychedelic therapy. By showcasing the transformative potential of proper professional support, the practice aims to highlight the difference it can make in patients' mental health journeys.

The practice stresses the importance of recognizing ketamine's potential for addiction when used excessively and without proper support. As with any substance, ketamine carries the risk of abuse and dependency. It's crucial for individuals to follow prescribed dosages and treatment plans under the guidance of qualified professionals to ensure safe and appropriate use.

Curated strongly advises individuals to consult with a qualified healthcare professional before making decisions concerning their mental health. By seeking expert guidance, individuals can receive personalized support tailored to their specific needs during ketamine-assisted therapy sessions.

Curated Mental Health's team of professionals is dedicated to providing a positive, safe, and nurturing environment for patients' mental health journeys. The practice ensures that patients receive the highest standard of care, focusing on their comfort and adherence to safety protocols.

For more information about Curated Mental Health and to explore the transformative potential of ketamine-assisted therapy, please visit www.curatedmentalhealth.com or contact (917) 451-7018.

ATLANTA, July 14, 2023 (Newswire.com) - Bilal Shaukat, DO, a second-year emergency medicine resident in Brooklyn is the 2023 winner of the 6th Annual ApolloMD Emergency Medicine Scholarship for Residents.

Dr. Shaukat describes emergency medicine as "the privilege of serving humanity in the most extraordinary way possible."

Yogin Patel, MD, president of ApolloMD, said in announcing this year's winner, "The dedication that our young physician colleagues bring to the profession is incredibly inspiring, especially in light of the demanding roles they play in an ever-changing environment. ApolloMD understands the challenges of emergency medicine and is proud to support our profession's rising stars."

The company's scholarship is open to applicants:

• In good standing with a U.S. allopathic or osteopathic medical school
• Pursuing a career in emergency medicine
• Participating in the National Resident Matching Program or training in an Emergency Medicine Residency Program

Consideration is given for achievements and leadership/membership in accredited medical societies/organizations.

"Beautiful side of emergency medicine"

Dr. Shaukat grew up in Queens, NY, completed undergraduate studies at Queens College, and graduated in 2021 from The New York Institute of Technology College of Osteopathic Medicine (NYIT-COM) in Old Westbury, NY.

He compares emergency medicine to "a place where each day presents new puzzles, where you're always on your toes, never sure what the next moment will bring."

Dr. Shaukat also embraces what he calls the "beautiful side of emergency medicine people often overlook — the raw, unfiltered essence of human connection. We're the first point of contact for patients at their most vulnerable moments. We hold their hands (literally and metaphorically), lend an ear or a shoulder to cry on and guide them through the store. We play detective, teacher, counselor, and healer all at once. We're like a Swiss Army knife of medicine — always ready, always versatile."

An avid weightlifter, hiker, and traveler, Dr. Shaukat's specific areas of medical interest include sports medicine and administration.

"Entirety of the human experience"

"In emergency medicine, you witness the entirety of the human experience, from the miracle of birth to the finality of death, all within the confines of the ED. It's a microcosm of life itself, filled with uncertainty, fear, hope, joy, loss, and triumph. Despite the grueling hours and the sleep deprivation, there's nowhere else I'd rather be. I'm hopelessly, irrevocably in love with emergency medicine." - Bilal Shaukat, DO

Now in its sixth year, ApolloMD's scholarship program supports medical residents pursuing a career in emergency medicine. It reflects ApolloMD's commitment to supporting resident physicians eager to pursue their passion for emergency medicine and high-quality, patient-centered health care.

Scholarship funds help the winner defray the costs of medical education. Applications open each year in mid-March.  

About ApolloMD

ApolloMD partners with more than 100 leading hospitals and health systems nationwide to provide Emergency Medicine, Hospital Medicine, and Revenue Cycle Management services. Our high-touch, solution-based approach emphasizes quality, efficiency, and patient experience. Learn more about our growing team today.

MediRoutes Logo

NEW YORK, July 14, 2023 (Newswire.com) - MediRoutes, the leading provider of Non-Emergency Medical Transportation (NEMT) software solutions, is thrilled to announce its recent integration with the 5.5 version of Medical Answering Services (MAS) API. This integration equips New York-based transportation providers with innovative tools to navigate the latest Medicaid regulations, including a mandatory shift towards digitization.

With this integration, transportation providers across New York State can streamline their operations using MediRoutes' advanced features like real-time GPS tracking, automated dispatching, and trip scheduling.

"Our integration with MAS is designed to provide transportation providers with the necessary tools to comply with the latest New York Medicaid regulations," said David Reinkensmeyer, COO of MediRoutes. 

"We understand the challenges transportation providers face in New York and are committed to helping them manage their operations effectively and more efficiently." -Reinkensmeyer -

Medicaid regulations in New York are constantly evolving, and it can be challenging for transportation providers to keep up with the latest changes. MediRoutes' integration ensures that its software is compliant with the latest regulations, making it easier for providers to navigate the day-to-day operations of running their business. 

MediRoutes is dedicated to delivering industry-leading software solutions that elevate the transportation providers' business. The MediRoutes platform is user-friendly and customizable to the unique needs of every transportation provider.

Reinkensmeyer further adds, "Our team's tireless efforts to integrate with MAS have paid off, and we're confident that our platform will significantly simplify the management of transportation operations."

About MediRoutes:

For over a decade, MediRoutes has offered its state-of-the-art NEMT software to thousands of transportation providers across the United States. The software enhances operational efficiency through real-time scheduling, dispatching, billing, and advanced reporting. To learn more about MediRoutes and its services, visit www.mediroutes.com.